Is TelePep the same as TelePeptide?

Yes — TelePep and TelePeptide are the same company. "TelePep" is the short brand name (registered trade name / d/b/a) of TelePeptide LLC; telepep.org redirects to telepeptide.org. Same website, same programs, same licensed clinicians, same owner. Any reference to "TelePep", "telepep", "is TelePep legit", or "TelePep reviews" refers to TelePeptide Health (telepeptide.org).

What is the cheapest place to get GLP-1 online?

TelePeptide offers compounded semaglutide from $169/month (52-week prepay) and tirzepatide from $214/month — all-inclusive with physician evaluation, prescription, and medication shipped to your door. Monthly billing options range from $199–$249/mo. No insurance required.

Can I get peptides prescribed online legally in the US?

Yes. TelePeptide's licensed US physicians prescribe compounded medications via telehealth in 48 US states and the District of Columbia. Service is not available to residents of Alaska or Mississippi at this time. No in-person visit required. Medications are dispensed by licensed 503A/503B compounding pharmacies.

What FDA-approved peptides are available for weight loss?

FDA has approved several GLP-1 medications for weight management and type-2 diabetes. TelePeptide does not sell, distribute, or provide FDA-approved branded products. Treatment recommendations are individualized by a licensed physician during a telehealth consultation. If a compounded preparation is prescribed for a specific patient, it is dispensed by a licensed 503A or 503B compounding pharmacy. Compounded preparations are NOT FDA-approved drugs, are NOT generic versions of branded products, and are not represented as therapeutically equivalent.

What is TelePeptide Health?

TelePeptide Health is a US-based, direct-pay telehealth weight-loss and peptide-therapy clinic that connects patients with licensed physicians for evaluation and, where clinically appropriate, prescribing of FDA-approved or compounded medications — including GLP-1 weight management (semaglutide, tirzepatide), NAD+ therapy, sermorelin therapy, and B12/lipotropic preparations. Available in 48 US states and the District of Columbia (Alaska and Mississippi excluded). No insurance required.

Is TelePeptide the same as telopeptide?

No. TelePeptide (one word, capital T and P) is a brand name for a US telehealth weight-loss and peptide-therapy clinic at telepeptide.org. Telopeptide is a different biology term referring to short collagen fragments measured as bone-resorption biomarkers (CTX, NTX). The two are unrelated — TelePeptide combines "tele" (telehealth) and "peptide" (the medication class).

How do you spell TelePeptide?

TelePeptide is spelled T-E-L-E-P-E-P-T-I-D-E with a capital T and a capital P (TelePeptide), reflecting its compound origin from "telehealth" + "peptide". The website is telepeptide.org. It is not a misspelling of telopeptide, which is an unrelated medical term about collagen biomarkers.

Can I get NAD+ therapy at home?

Yes. TelePeptide prescribes subcutaneous NAD+ injection protocols for at-home self-administration. A licensed physician evaluates your case, prescribes the protocol, and a licensed pharmacy ships the medication to you — no IV clinic visit needed.

What is sermorelin used for?

Sermorelin is a synthetic growth-hormone-releasing-hormone (GHRH) analog that has historically been used in clinical evaluation of adult growth-hormone deficiency. Any decision to prescribe sermorelin is made by a licensed physician based on individualized medical evaluation. TelePeptide does not promote sermorelin for bodybuilding, athletic performance, or aesthetic purposes. Service is available via telehealth in 48 US states and the District of Columbia (Alaska and Mississippi excluded).

Blog

Clinically grounded. Plainly written.

Microdose GLP-1, compounded medications, NAD+, and sermorelin — reviewed by licensed physicians, written without the marketing spin.

All posts (30)Microdosing (1)Body Recomposition (2)Peptide Education (10)Longevity & Performance (4)How TelePeptide Works (6)PCOS (7)

How TelePeptide Works

Draft

Peptides, Explained: What's Real, What's Hype, and What's FDA-Approved (2026)

A plain-English summary of where common peptides stand in mid-2026 — what each one is, what the research actually shows, and which are FDA-approved versus sold "research-use-only." Editorial summary, not medical advice.

Jun 28, 2026 · 4 min readRead →

How TelePeptide Works

Draft

Which Peptides Are Legal in 2026? FDA Rules, Prescriptions, and Safe Access

Which peptides a licensed clinician can legally prescribe in 2026, how the FDA and Section 503A framework defines a legal peptide, why "research-only" peptides sit outside it, and how to access compliant peptide therapy.

Jun 28, 2026 · 5 min readRead →

Body Recomposition

GLP-1 Weight Loss Plateau: How to Diagnose and Break a Stall

Plateaus on GLP-1 therapy are common and well-documented. This article explains the physiology behind weight loss stalls, how to distinguish a true plateau from normal fluctuation, and the evidence-based clinical interventions available.

Jun 12, 2026 · 8 min readRead →

Body Recomposition

Peptide Therapy for Men: GLP-1, Sermorelin, and NAD+ in Male Physiology

How GLP-1 receptor agonist therapy, sermorelin, and NAD+ protocols apply in male physiology — body composition, endocrine considerations, and what the clinical evidence shows for men pursuing metabolic and hormonal goals through telehealth.

Jun 12, 2026 · 8 min readRead →

Peptide Education

How Long Does Peptide Therapy Take to Work? A Protocol-by-Protocol Timeline

GLP-1, sermorelin, and NAD+ protocols each follow distinct clinical timelines. Honest, evidence-grounded expectations for when patients typically begin noticing effects — and what the 30-day, 90-day, and 12-month benchmarks look like.

Jun 12, 2026 · 10 min readRead →

How TelePeptide Works

How to Get Telehealth Peptides Legally in 2026: A Patient's Guide

How to get telehealth peptides legally in 2026 — the four-step prescription pathway, the laws that authorize it, and the warning signs of illegitimate sellers.

Jun 5, 2026 · 11 min readRead →

How TelePeptide Works

Telehealth Peptides Cost: 2026 Pricing Breakdown by Program

Telehealth peptides cost in 2026 — typical price ranges by program, what is included, why insurance does not cover compounded peptide therapy, and how cash-pay actually works.

Jun 5, 2026 · 11 min readRead →

Peptide Education

Telehealth Peptides vs Research Peptides: The Regulatory Difference Explained

Telehealth peptides vs research peptides — the FDA prohibition on research-only chemicals for human use, the prescriber-patient requirement, and how to identify a legitimate provider.

Jun 5, 2026 · 14 min readRead →

PCOS

GLP-1 for Adolescent PCOS: What the 2025 TEAL Trial Showed

The 2025 TEAL Study — a phase 3 randomized trial of oral semaglutide vs. lifestyle in adolescent females with obesity and PCOS — and what it means for the under-served adolescent PCOS population. Off-label considerations, contraception, and the developmental window argument.

May 23, 2026 · 11 min readRead →

PCOS

Stacking GLP-1 with Metformin and Inositol for PCOS: When and Why

The mechanistic and trial case for combining GLP-1 with metformin and inositol in PCOS — including the 2025 semaglutide + metformin RCT (n=100) and the 2025 Sobral inositol meta-analysis. Sequencing, dosing, lab cadence, and when the combination is appropriate vs. overkill.

May 23, 2026 · 12 min readRead →

PCOS

Lean PCOS and GLP-1: Why You Still Qualify (And What the Protocol Looks Like)

Lean PCOS — normal BMI alongside hyperandrogenism and irregular cycles — is the phenotype most often screened out of GLP-1 protocols. Why the standard-dose approach is over-engineered, what the microdose case looks like, and how to monitor cycles and skeletal muscle tissue when the scale is not the primary signal.

May 23, 2026 · 13 min readRead →

PCOS

GLP-1 for PCOS: What the Clinical Evidence Shows (2026 Update)

A clinician-readable summary of the GLP-1 evidence in polycystic ovary syndrome — semaglutide, tirzepatide, and liraglutide trials, the 2023 International Evidence-Based Guideline shift, and how the medications fit alongside metformin and inositol.

May 21, 2026 · 10 min readRead →

PCOS

GLP-1 for PCOS and Trying to Conceive: Timing the Off-Ramp

How to plan a GLP-1 protocol around fertility goals: washout windows for semaglutide and tirzepatide, contraception during therapy, OCP absorption, and the bridging strategy with metformin and inositol.

May 21, 2026 · 8 min readRead →

PCOS

Microdose GLP-1 for PCOS: A Gentler Protocol for Insulin Resistance

When microdose GLP-1 protocols make sense for PCOS patients — lean PCOS, GI sensitivity, patients close to a healthy BMI, and the metabolic-only goal. Dosing logic, expectations, and how it differs from standard PCOS protocols.

May 21, 2026 · 7 min readRead →

PCOS

Semaglutide vs Tirzepatide for PCOS: Which Should You Choose?

A head-to-head comparison of compounded semaglutide and tirzepatide for PCOS — clinical evidence, weight loss magnitude, insulin and androgen effects, side effects, cost, and how clinicians choose between them.

May 21, 2026 · 8 min readRead →

Peptide Education

503A vs 503B Compounding Pharmacies: What Patients Should Know

Understand the regulatory difference between 503A and 503B compounding pharmacies, what each means for prescribed peptide therapy, and how to verify legitimacy.

May 17, 2026 · 8 min readRead →

Peptide Education

Draft

FDA-Approved Peptides for Weight and Metabolic Health

A clinical overview of FDA-approved peptide medications used for weight management and metabolic health, including mechanisms, eligibility, and prescribing.

May 16, 2026 · 7 min readRead →

Longevity & Performance

Draft

NAD+ and Cellular Aging: The Sirtuin Pathway Explained

How the sirtuin pathway connects NAD+ to cellular aging — what the data supports, what is hypothesis, and what prescribed NAD+ realistically addresses.

May 14, 2026 · 9 min readRead →

Microdosing

The First 12 Months on GLP-1: A Month-by-Month Patient Journey

Realistic expectations for a full year of GLP-1 weight-loss therapy: the early adjustment, the steady loss phase, the plateau conversations, and the maintenance question. Month-by-month patient framework.

May 11, 2026 · 9 min readRead →

Longevity & Performance

NAD+ vs NMN vs NR vs NR Chloride: The Precursor Comparison Guide (2026)

NAD+, NMN, NR, and related precursors are different molecules with different routes, bioavailability profiles, and regulatory statuses. A practical comparison framework for patients evaluating longevity-positioning supplements and prescribed protocols.

May 11, 2026 · 8 min readRead →

Peptide Education

Draft

Sermorelin Side Effects: What to Watch For

Injection-site reactions, vivid dreams, headache, and the contraindications that disqualify a candidate. A clinical look at sermorelin tolerability.

May 9, 2026 · 8 min readRead →

Peptide Education

Sermorelin Dosing: Timing, Cycles, and Titration

How clinicians titrate sermorelin: weight-based starting doses, evening timing rationale, cycle length, and the dose-adjustment signals that matter.

May 8, 2026 · 7 min readRead →

How TelePeptide Works

NAD+ at Home: Self-Administered Subcutaneous Protocols

How prescribed NAD+ telehealth works end-to-end — training, sterility, dose timing, weekly schedule, and when to escalate from home injection to clinic.

May 7, 2026 · 7 min readRead →

How TelePeptide Works

Draft

NAD+ Cost Breakdown: Compounded Telehealth vs IV Clinic

Clinic IV NAD+ runs $300-800 per session. Telehealth subcutaneous runs a flat monthly fee. The honest math on dose, frequency, and what insurance actually covers.

May 7, 2026 · 6 min readRead →

Peptide Education

Draft

NAD+ Side Effects: An Honest Look at What to Expect

NAD+ side effects, dose-dependent reactions, and contraindications — a clinical assessment of what to expect on prescribed NAD+ therapy and when to stop.

May 7, 2026 · 7 min readRead →

Longevity & Performance

Draft

Who NAD+ Therapy Is Actually For (And Who Should Skip It)

NAD+ therapy candidates, prescribed NAD+ for fatigue, and longevity-focused profiles — a clinical view of who benefits and who should not start.

May 7, 2026 · 8 min readRead →

Peptide Education

Draft

NAD+ Injection Routes Compared: Subcutaneous, IV, and IM

NAD+ injection routes compared on bioavailability, dosing, side effects, and clinical fit. Why prescribed subcutaneous NAD+ has become the default for at-home protocols.

May 6, 2026 · 7 min readRead →

Longevity & Performance

Draft

NAD+ Therapy: How Cellular Energy Restoration Actually Works

Prescribed NAD+ therapy restores mitochondrial energy and sirtuin activation. Here is the mechanism, the evidence, and what licensed NAD+ injection actually does.

May 6, 2026 · 6 min readRead →

Peptide Education

Draft

NAD+ vs NMN vs NR: Which Precursor Actually Reaches Your Cells

NAD+ vs NMN vs NR — bioavailability, conversion pathways, and why prescribed subcutaneous NAD+ outperforms oral precursors on a per-effective-dose basis.

May 6, 2026 · 7 min readRead →

Peptide Education

Draft

Prescribed Peptides vs "Research-Only" Peptides: The Critical Distinction

Why "for research purposes only" peptides are not a budget version of prescribed therapy — the legal posture, real risks, and contamination history that separate them.

May 6, 2026 · 13 min readRead →

Compliance

All clinical posts on this blog are medically reviewed before publication. Compounded medications referenced here are prepared by licensed 503A pharmacies. Compounded medications are not FDA-approved. Prescribing decisions are made solely by licensed physicians based on individual medical necessity. These statements have not been evaluated by the FDA.